Scholarly Index
Bradford D. Gessner
Pfizer (United States); 47,925 total citations; 426 total publications; best world rank #10
Pfizer (United States)
47,925Total citations
426Total publications
69H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pneumonia and Respiratory Infections | Lifetime | 135 | US 65 | 99.41 |
| Respiratory viral infections research | Lifetime | 168 | US 96 | 99.23 |
| Bacterial Infections and Vaccines | Lifetime | 115 | US 53 | 98.85 |
| Influenza Virus Research Studies | Lifetime | 286 | US 135 | 98.58 |
| Vaccine Coverage and Hesitancy | Lifetime | 235 | US 119 | 98.19 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 670 | US 283 | 96.86 |
| Travel-related health issues | Lifetime | 651 | US 167 | 83.56 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 10 | US 3 | 98.62 |
| Pneumonia and Respiratory Infections | 2021-2025 | 19 | US 3 | 99.15 |
| Respiratory viral infections research | 2021-2025 | 27 | US 10 | 99.12 |
| Viral Infections and Vectors | 2021-2025 | 989 | US 243 | 88.89 |
| Bacterial Infections and Vaccines | 2021-2025 | 270 | US 64 | 86.81 |
| Influenza Virus Research Studies | 2021-2025 | 671 | US 248 | 88.02 |
| Vector-borne infectious diseases | 2021-2025 | 653 | US 178 | 85.76 |